TRANSFORMED FOLLICULAR LYMPHOMA (TFL)
Clinical trials for TRANSFORMED FOLLICULAR LYMPHOMA (TFL) explained in plain language.
Never miss a new study
Get alerted when new TRANSFORMED FOLLICULAR LYMPHOMA (TFL) trials appear
Sign up with your email to follow new studies for TRANSFORMED FOLLICULAR LYMPHOMA (TFL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Triple-Target immune cell therapy enters first human trial for tough blood cancers
Disease control ENROLLING_BY_INVITATIONThis is a first-in-human safety study testing a new, experimental CAR-T cell therapy called CAR19.20.22 in adults with B-cell lymphomas that have returned or not responded to at least two prior treatments. The therapy uses the patient's own immune cells, engineered to attack canc…
Matched conditions: TRANSFORMED FOLLICULAR LYMPHOMA (TFL)
Phase: PHASE1 • Sponsor: University of Maryland, Baltimore • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Shielding cancer fighters: can a simple vaccine timing trick prevent deadly infections?
Prevention OngoingThis study is testing whether giving a pneumonia vaccine before and after a powerful cancer treatment called CAR T cell therapy can better protect patients from serious infections. It involves 26 adults with certain types of B-cell lymphoma who are scheduled for CAR T therapy. Th…
Matched conditions: TRANSFORMED FOLLICULAR LYMPHOMA (TFL)
Phase: PHASE2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Prevention
Last updated Mar 24, 2026 12:02 UTC